Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alpek's other long-term liabilities for the quarter that ended in Jun. 2026 was MXN2,572 Mil.
Alpek's quarterly other long-term liabilities
declined
from Dec. 2025 (MXN3,069 Mil) to Mar. 2026 (MXN2,939 Mil) and
declined
from Mar. 2026 (MXN2,939 Mil) to Jun. 2026 (MXN2,572 Mil).
Alpek's annual other long-term liabilities
increased
from Dec. 2023 (MXN3,268 Mil) to Dec. 2024 (MXN4,914 Mil) but then
declined
from Dec. 2024 (MXN4,914 Mil) to Dec. 2025 (MXN3,069 Mil).
The historical data trend for Alpek's Other Long-Term Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.
What does a Other Long-Term Liabilities of MXN2,572 Mil mean?
Alpek (MEX:ALPEKA) has a Other Long-Term Liabilities of MXN2,572 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Alpek and its competitors.
Is Alpek's Other Long-Term Liabilities too high?
Alpek's current Other Long-Term Liabilities is MXN2,572 Mil. Overall, Alpek has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alpek's Other Long-Term Liabilities compare to LIN and SHW?
Alpek's Other Long-Term Liabilities of MXN2,572 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Chemicals company?
A good Other Long-Term Liabilities depends on the Chemicals industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Alpek and its competitors. Alpek's current Other Long-Term Liabilities is MXN2,572 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpek stock overvalued right now?
Based on GuruFocus' analysis, Alpek (MEX:ALPEKA) is currently considered Fairly Valued. The stock's GF Value™ is MXN11.61, compared to a current price of MXN12.26 — trading 5.6% above its estimated fair value. The current Other Long-Term Liabilities is MXN2,572 Mil. Alpek's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Alpek (MEX:ALPEKA), the current Other Long-Term Liabilities is MXN2,572 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alpek (MEX:ALPEKA) Overvalued in 2026?
Based on GuruFocus' analysis, Alpek stock appears to be overvalued.
The current stock price of MXN12.26 is trading 5.6% above its estimated GF Value™ of MXN11.61.
GuruFocus considers Alpek to be Fairly Valued.
Key valuation signals for MEX:ALPEKA:
Other Long-Term Liabilities: MXN2,572 Mil
GF Value™: MXN11.61 vs. price of MXN12.26 (5.6% above fair value)
No single metric tells the full story. See the MEX:ALPEKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alpek SA is a petrochemical company with operations through two business segments: Polyester and Plastic and Chemicals. The Polyester segment comprises the production of purified terephthalic acid (PTA), polyethylene terephthalate (PET), recycled PET (rPET), and polyester fibers, which are mainly used for food and beverage packaging, textile and industrial filament markets, and The Plastics & Chemicals business segment comprises the production of polypropylene (PP), expandable styrene (EPS and Arcel), fertilizers and other chemicals, which serves a wide range of markets, including the consumer goods, automotive, construction, agriculture, pharmaceutical, and other markets. The company derives a majority of its revenue from the polyester segment.
63GF Score
Get the complete analysis for MEX:ALPEKA
Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ALPEKA has been successfully added to your 
